A randomized, double-blind, placebo-controlled phase II...

  • Main
  • 2016 / 01
  • A randomized, double-blind, placebo-controlled phase II...

A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma

Ciuleanu, T., Bazin, I., Lungulescu, D., Miron, L., Bondarenko, I., Deptala, A., Rodriguez-Torres, M., Giantonio, B., Fox, N. L., Wissel, P., Egger, J., Ding, M., Kalyani, R. N., Humphreys, R., Gribbi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw004
Date:
January, 2016
File:
PDF, 710 KB
english, 2016
Conversion to is in progress
Conversion to is failed